Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 5:01 AM
Ignite Modification Date:
2025-12-25 @ 5:01 AM
NCT ID:
NCT02157818
Eligibility Criteria:
Inclusion Criteria:
* Patients who visit Seoul National University Hospital between 2014.04 - 2015.04
* Patients who undergo EBUS-TBNA during the period
* Aged between 18-75
* Patients who meet the criteria of American Society of Anesthesiologists (ASA) physical status classification I-III
Exclusion Criteria:
* American Society of Anesthesiologists (ASA) physical status classification \>3
* Have glomerular filtration rate (GFR) less than 15ml/min 1.73m2 or undergoing hemodialysis
* End stage liver disease.
* Impaired ventricular functions (EF \<30%)
* Patients with baseline oxygen desaturation (resting SpO2 \<90%)
* Asthma or chronic obstructive pulmonary disease or a forced expiratory volume in 1 s (FEV1)of \< 1.0 liter
* Bradycardia \[baseline heart rate (HR)\< 60 beats/min\]
* Hypotension \[baseline systolic arterial pressure (SAP) \< 100 mm Hg\]
* Pregnant state
* Those intolerant or with an allergy to the study drug
* those unable or who refused to give informed consent
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
75 Years
Study:
NCT02157818
Study Brief:
Protocol Section:
NCT02157818